#de novo drug discovery
Discover 2 curated intelligence briefings related to this specific topic.

Health & Medicine
The Bioenergetic Pivot: Why Mitochondria are the Real Arbiters of Human Longevity
The global medical establishment is shifting its gaze from genetic markers to the bioenergetic engine of the cell. This transition from treating symptoms to optimizing mitochondrial efficiency represents a fundamental rewrite of the human aging process.
Read Analysis

Technology & Innovation
Distributed Intelligence Dismantles the Pharma Hub
The concentration of pharmaceutical power in a few Western hubs is evaporating as predictive AI and distributed manufacturing models move from theory to commercial scale.
Read Analysis